In this webinar, Dr Bob Johnson, Emeritus Consultant in pain management and international expert on the shingles vaccination and the prevention and management of post-herpetic neuralgia joins Professor Matthew Ridd, GP and Chief Investigator on the Amitriptyline for the prevention of post-herpetic neuralgia trial (ATHENA), Centre for Academic Primary Care, University of Bristol, to talk through the epidemiology, incidence, risk factors and acute treatment for shingles, and the prevention and treatment of the most common complication, post-herpetic neuralgia (pain after shingles).
See: www.bristol.ac.uk/athena-study for more information about the ATHENA Shingles Trial.
15 окт 2024
